200 related articles for article (PubMed ID: 19106610)
21. Dyskeratosis congenita.
Marrone A; Mason PJ
Cell Mol Life Sci; 2003 Mar; 60(3):507-17. PubMed ID: 12737310
[TBL] [Abstract][Full Text] [Related]
22. Stem cells, telomerase and dyskeratosis congenita.
Mason PJ
Bioessays; 2003 Feb; 25(2):126-33. PubMed ID: 12539238
[TBL] [Abstract][Full Text] [Related]
23. Dyskeratosis congenita, stem cells and telomeres.
Kirwan M; Dokal I
Biochim Biophys Acta; 2009 Apr; 1792(4):371-9. PubMed ID: 19419704
[TBL] [Abstract][Full Text] [Related]
24. Mouse dyskerin mutations affect accumulation of telomerase RNA and small nucleolar RNA, telomerase activity, and ribosomal RNA processing.
Mochizuki Y; He J; Kulkarni S; Bessler M; Mason PJ
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10756-61. PubMed ID: 15240872
[TBL] [Abstract][Full Text] [Related]
25. Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita.
Vulliamy TJ; Knight SW; Mason PJ; Dokal I
Blood Cells Mol Dis; 2001; 27(2):353-7. PubMed ID: 11259155
[TBL] [Abstract][Full Text] [Related]
26. Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer.
Marrone A; Dokal I
Expert Rev Mol Med; 2004 Dec; 6(26):1-23. PubMed ID: 15613268
[TBL] [Abstract][Full Text] [Related]
27. Acute dyskerin depletion triggers cellular senescence and renders osteosarcoma cells resistant to genotoxic stress-induced apoptosis.
Lin P; Mobasher ME; Alawi F
Biochem Biophys Res Commun; 2014 Apr; 446(4):1268-75. PubMed ID: 24690175
[TBL] [Abstract][Full Text] [Related]
28. Dyskerin: an essential pseudouridine synthase with multifaceted roles in ribosome biogenesis, splicing, and telomere maintenance.
Garus A; Autexier C
RNA; 2021 Dec; 27(12):1441-1458. PubMed ID: 34556550
[TBL] [Abstract][Full Text] [Related]
29. Acute telomerase components depletion triggers oxidative stress as an early event previous to telomeric shortening.
Ibáñez-Cabellos JS; Pérez-Machado G; Seco-Cervera M; Berenguer-Pascual E; García-Giménez JL; Pallardó FV
Redox Biol; 2018 Apr; 14():398-408. PubMed ID: 29055871
[TBL] [Abstract][Full Text] [Related]
30. Single-molecule analysis of the human telomerase RNA.dyskerin interaction and the effect of dyskeratosis congenita mutations.
Ashbridge B; Orte A; Yeoman JA; Kirwan M; Vulliamy T; Dokal I; Klenerman D; Balasubramanian S
Biochemistry; 2009 Nov; 48(46):10858-65. PubMed ID: 19835419
[TBL] [Abstract][Full Text] [Related]
31. The C-terminal extension of dyskerin is a dyskeratosis congenita mutational hotspot that modulates interaction with telomerase RNA and subcellular localization.
Qin J; Garus A; Autexier C
Hum Mol Genet; 2024 Feb; 33(4):318-332. PubMed ID: 37879098
[TBL] [Abstract][Full Text] [Related]
32. A telomerase component is defective in the human disease dyskeratosis congenita.
Mitchell JR; Wood E; Collins K
Nature; 1999 Dec; 402(6761):551-5. PubMed ID: 10591218
[TBL] [Abstract][Full Text] [Related]
33. Targeted disruption of Dkc1, the gene mutated in X-linked dyskeratosis congenita, causes embryonic lethality in mice.
He J; Navarrete S; Jasinski M; Vulliamy T; Dokal I; Bessler M; Mason PJ
Oncogene; 2002 Oct; 21(50):7740-4. PubMed ID: 12400016
[TBL] [Abstract][Full Text] [Related]
34. Dyskeratosis congenita and telomerase.
Bessler M; Wilson DB; Mason PJ
Curr Opin Pediatr; 2004 Feb; 16(1):23-8. PubMed ID: 14758110
[TBL] [Abstract][Full Text] [Related]
35. Dyskeratosis congenita: a genetic disorder of many faces.
Kirwan M; Dokal I
Clin Genet; 2008 Feb; 73(2):103-12. PubMed ID: 18005359
[TBL] [Abstract][Full Text] [Related]
36. Expression of the genetic suppressor element 24.2 (GSE24.2) decreases DNA damage and oxidative stress in X-linked dyskeratosis congenita cells.
Manguan-Garcia C; Pintado-Berninches L; Carrillo J; Machado-Pinilla R; Sastre L; Pérez-Quilis C; Esmoris I; Gimeno A; García-Giménez JL; Pallardó FV; Perona R
PLoS One; 2014; 9(7):e101424. PubMed ID: 24987982
[TBL] [Abstract][Full Text] [Related]
37. Dyskeratosis congenita: advances in the understanding of the telomerase defect and the role of stem cell transplantation.
de la Fuente J; Dokal I
Pediatr Transplant; 2007 Sep; 11(6):584-94. PubMed ID: 17663679
[TBL] [Abstract][Full Text] [Related]
38. Dyskeratosis congenita -- a disease of dysfunctional telomere maintenance.
Mason PJ; Wilson DB; Bessler M
Curr Mol Med; 2005 Mar; 5(2):159-70. PubMed ID: 15974869
[TBL] [Abstract][Full Text] [Related]
39. N-terminal residues of human dyskerin are required for interactions with telomerase RNA that prevent RNA degradation.
MacNeil DE; Lambert-Lanteigne P; Autexier C
Nucleic Acids Res; 2019 Jun; 47(10):5368-5380. PubMed ID: 30931479
[TBL] [Abstract][Full Text] [Related]
40. Sex differences in telomere length, lifespan, and embryonic dyskerin levels.
Lansdorp PM
Aging Cell; 2022 May; 21(5):e13614. PubMed ID: 35441417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
